Your browser doesn't support javascript.
loading
Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer.
Asami, Yuka; Kobayashi Kato, Mayumi; Hiranuma, Kengo; Matsuda, Maiko; Shimada, Yoko; Ishikawa, Mitsuya; Koyama, Takafumi; Komatsu, Masaaki; Hamamoto, Ryuji; Nagashima, Minoru; Terao, Yasuhisa; Itakura, Atsuo; Kohno, Takashi; Sekizawa, Akihiko; Matsumoto, Koji; Kato, Tomoyasu; Shiraishi, Kouya; Yoshida, Hiroshi.
Affiliation
  • Asami Y; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
  • Kobayashi Kato M; Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, 142-8555, Japan.
  • Hiranuma K; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
  • Matsuda M; Department of Gynecology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
  • Shimada Y; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
  • Ishikawa M; Department of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, 113-8421, Japan.
  • Koyama T; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
  • Komatsu M; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
  • Hamamoto R; Department of Gynecology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
  • Nagashima M; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
  • Terao Y; Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
  • Itakura A; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, 103-0027, Japan.
  • Kohno T; Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
  • Sekizawa A; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, 103-0027, Japan.
  • Matsumoto K; Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, 142-8555, Japan.
  • Kato T; Department of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, 113-8421, Japan.
  • Shiraishi K; Department of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, 113-8421, Japan.
  • Yoshida H; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Br J Cancer ; 128(8): 1582-1591, 2023 04.
Article in En | MEDLINE | ID: mdl-36797358
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Endometrial Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Br J Cancer Year: 2023 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Endometrial Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Br J Cancer Year: 2023 Type: Article Affiliation country: Japan